Allopurinol
- Product NDC
- 66267-224
- 11-digit product format
- 662670224
- Labeler code
- 66267
- Product ID
- 66267-224_b8a74629-4bda-ab84-e053-2a95a90aace1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ALLOPURINOL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA203154
- Marketing category
- ANDA
- Marketing start
- 2015-04-29
- Marketing end
- 0000-00-00
- Substance
- ALLOPURINOL
- Active strength
- 300 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66267-224-30 | Allopurinol | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
| 66267-224-60 | Allopurinol | 60 in 1 BOTTLE | TABLET | 60 | | 4 |
| 66267-224-90 | Allopurinol | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66267-224 | ALLOPURINOL TABLET [NUCARE PHARMACEUTICALS, INC.] | 4 | Legacy NDC, 3 package rows | 20210112_3f14a94b-0c6e-1fec-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66267-224-30 | 66267022430 | 30 TABLET in 1 BOTTLE (66267-224-30) | 30 tablet | 2016-10-17 | 0000-00-00 | No | No | Current |
| 66267-224-60 | 66267022460 | 60 TABLET in 1 BOTTLE (66267-224-60) | 60 tablet | 2016-10-17 | 0000-00-00 | No | No | Current |
| 66267-224-90 | 66267022490 | 90 TABLET in 1 BOTTLE (66267-224-90) | 90 tablet | 2016-10-17 | 0000-00-00 | No | No | Current |